We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


First Application of Haselmeier’s Axis-D Injection Pen is Launched

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Haselmeier has announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck Serono, a division of Merck KGaA, Germany, the new injection device has been designed to allow self injection by patients of a ready to use biopharmaceutical solution for injection.

“With the Axis pen platform it is easy to tailor the injection device to various needs. Following our client’s specifications, we have developed a device that enables users to adjust the volume of the injection and reuse the pen several times until the cartridge is empty. For security reasons, we added a function to the pen to immediately confirm that a complete dose was delivered, or to indicate the missing amount if an incomplete dose is injected,” said Volker Wirth, Director Business Development & Marketing at Haselmeier.

Wirth continued, “We are proud of this successful collaboration with Merck Serono and we look forward to continuing our business relationship in the future.”

The Axis pen platform is available as a reusable or disposable multi-use pen which features adjustable dosing.

The pen design is based on an innovative technology featuring a sliding dose window which allows easy reading of the dose and provides reduced risk of incorrect dosing.

Available in metal or plastic, the Axis pen is compatible with 3ml cartridges, all fill volumes and can be customized to meet any patient needs.